Literature DB >> 25618436

The changing epidemiology of bacteraemic osteoarticular infections in the early 21st century.

O Murillo1, I Grau2, J Lora-Tamayo2, J Gomez-Junyent2, A Ribera2, F Tubau3, J Ariza2, R Pallares2.   

Abstract

Osteoarticular infections (OAI), which are often associated with bacteraemia, seem to be increasing. We studied all patients with bacteraemia and concomitant OAI: septic arthritis (SA), vertebral osteomyelitis (VOM) or peripheral osteomyelitis (POM), which were seen at our institution (1985-2011). Data were extracted from a prospective protocol of bacteraemia cases recorded. Trends in main findings were considered in five periods. Major antibiotic resistance patterns were studied. A total of 601 cases of bacteraemic OAI, accounting for 1.8% of total bactaeremias, were studied: SA (48%), VOM (40%) and POM (17%). When comparing the 1985-91 and 2007-11 periods, the incidence of bacteraemic OAI increased from 2.34 to 5.78 episodes/100 000 inhabitants per year (p <0.001); and nosocomial and healthcare-related cases increased from 18% to 30% (p <0.001) and from 10% to 25% (p <0.001), respectively. Also, there was an increase of age (median, from 49 to 65 years, p <0.001), patients with comorbidities (23% to 59%, p <0.001), and device-related OAI (7% to 28%, p <0.001). Patterns of OAI were changing over time. Compared with younger patients, older adults (≥ 65 years) had more VOM, prosthetic-joint infections and enterococcal OAI. The percentage of OAI caused by methicillin-susceptible Staphylococcus aureus decreased, while those caused by methicillin-resistant S. aureus, streptococci, enterococci, and Gram-negative bacilli increased. There was a link between certain microorganisms with specific OAI and age of patients. Over the past three decades, bacteraemic OAI increased in association with aging and use of orthopaedic devices. Nosocomial and healthcare-related OAI increased, with a rise in multidrug-resistant bacteria. These trends should be considered when planning diagnostic and therapeutic guidelines for OAI.
Copyright © 2014 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bacteraemia; epidemiology; osteoarticular infections; osteomyelitis; septic arthritis; spondylodiscitis

Mesh:

Year:  2014        PMID: 25618436     DOI: 10.1016/j.cmi.2014.09.007

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  21 in total

1.  Clindamycin inhibits nociceptive response by reducing tumor necrosis factor-α and CXCL-1 production and activating opioidergic mechanisms.

Authors:  Felipe F Rodrigues; Marcela I Morais; Ivo S F Melo; Paulo S A Augusto; Marcela M G B Dutra; Sarah O A M Costa; Fábio C Costa; Franciele A Goulart; Alysson V Braga; Márcio M Coelho; Renes R Machado
Journal:  Inflammopharmacology       Date:  2019-11-25       Impact factor: 4.473

2.  Development and challenges in setting up an international bone infection registry.

Authors:  Stephen L Kates; Severine Hurni; Maio S Chen
Journal:  Arch Orthop Trauma Surg       Date:  2019-11-07       Impact factor: 3.067

3.  [Chameleon spondylodiscitis : Challenge for geriatricians].

Authors:  Werner Hofmann
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

4.  Prolonged suppressive antibiotic therapy for prosthetic joint infection in the elderly: a national multicentre cohort study.

Authors:  V Prendki; T Ferry; P Sergent; E Oziol; E Forestier; T Fraisse; S Tounes; S Ansart; J Gaillat; S Bayle; O Ruyer; F Borlot; G Le Falher; B Simorre; F-A Dauchy; S Greffe; T Bauer; E N Bell; B Martha; M Martinot; M Froidure; M Buisson; A Waldner; X Lemaire; A Bosseray; M Maillet; V Charvet; A Barrelet; B Wyplosz; M Noaillon; E Denes; E Beretti; M Berlioz-Thibal; V Meyssonnier; E Fourniols; L Tliba; A Eden; M Jean; C Arvieux; K Guignery-Kadri; C Ronde-Oustau; Y Hansmann; A Belkacem; F Bouchand; G Gavazzi; F Herrmann; J Stirnemann; A Dinh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-04-04       Impact factor: 3.267

5.  Acute osteomyelitis and septic arthritis in children : A referral hospital-based study in Iran.

Authors:  Shima Mahmoudi; Babak Pourakbari; Katayoun Borhani; Mahmoud Khodabandeh; Sepideh Keshavarz Valian; Alireza Aziz-Ahari; Setareh Mamishi
Journal:  Wien Med Wochenschr       Date:  2017-07-25

6.  Endocarditis associated with vertebral osteomyelitis and septic arthritis of the axial skeleton.

Authors:  Oscar Murillo; Imma Grau; Joan Gomez-Junyent; Celina Cabrera; Alba Ribera; Fe Tubau; Carmen Peña; Javier Ariza; Roman Pallares
Journal:  Infection       Date:  2018-02-02       Impact factor: 3.553

7.  Antimicrobial Formulations of Absorbable Bone Substitute Materials as Drug Carriers Based on Calcium Sulfate.

Authors:  D Pförringer; A Obermeier; M Kiokekli; H Büchner; S Vogt; A Stemberger; R Burgkart; M Lucke
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

8.  [Chameleon spondylodiscitis : Challenge for geriatricians].

Authors:  Werner Hofmann
Journal:  Z Gerontol Geriatr       Date:  2017-10-10       Impact factor: 1.281

9.  The Pitfalls of Febrile Jaundice. A Case Report.

Authors:  Maria Obreja; Andra Teodor; Daniela Leca; Alexandr Ceasovschih; Egidia Miftode
Journal:  J Crit Care Med (Targu Mures)       Date:  2016-05-09

10.  Pediatric Septic Arthritis and Osteomyelitis in the USA: A National KID Database Analysis.

Authors:  Gabriella Safdieh; Jason Silberman; Joseph Nguyen; Shevaun M Doyle; John S Blanco; David M Scher; Daniel W Green; Roger F Widmann; Emily R Dodwell
Journal:  HSS J       Date:  2018-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.